Score prediction of metastatic risk in gastrointestinal stromal tumours (GIST);Entwicklung eines malignitätsscores zur vorhersage der metastasierungswahrscheinlichkeit gastrointestinaler stromatumoren (GIST)

Zentralblatt fur Chirurgie

Volumn 132, Issue 6, 2007, Pages 509-514

  Wilmanns, Christoph ^a,c   Eggstein, S ^b   Ruf, G ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Helios Klinik Titisee Neustadt   (Germany)

^c St Elisabeth Krankenhaus   (Germany)

Author keywords

Gastrointestinal stromal tumours; Metastasis; Score

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TRACT; HUMAN; LIVER TUMOR; MALE; METASTASIS; METHODOLOGY; MIDDLE AGED; MITOSIS INDEX; MORTALITY; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GASTROINTESTINAL STROMAL TUMORS; GASTROINTESTINAL TRACT; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOTIC INDEX; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; RESEARCH DESIGN; RISK FACTORS; SURVIVAL RATE; TUMOR BURDEN;

EID: 37749009086     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-981365     Document Type: Article

References (13)

1. DeMatteo RP, Heinrich MC, El-Rifai WM, Demetri G. Clinical management of Gastrointestinal Stromal Tumors: before and after STI-571. Hum Pathol 2002; 33: 466-477
2. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors. Dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87
3. Fitzer CJ, O'Brian CA, Guillem JG, Weinstein IB. The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids. Carcinogenesis 1987; 8: 217-220
4. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33: 459-465
5. Franquemont DW. Differentiation and risk assessment of Gastrointestinal Stromal Tumors. Am J Clin Pathol 1995; 103: 41-47 6 Hunter K, Welch DR, Liu ET. Genetic background is an important determinant of metastatic potential. Nature Gen 2003; 34: 23-24
6. Jou T-S, Nelson WJ. Effects of regulated expression of mutant rhoA and racl small GTPases on the development of epithelial (MDCK) cell polarity. J Cell Biol 1998; 142: 85-100
7. Newman PL, Wadden C, Fletcher CDM. Gastrointestinal Stromal Tumours: correlation of immunophenotype with clinicopathological features. J Pathol 1991; 164: 107-117
8. Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen C-J, Xiao S, Tuveson DA, Demetri GD, Fletcher CDM, Fletcher JA. Kit activation is a ubiquitous feature of Gastrointestinal Stromal Tumors. Cancer Res 2001; 61: 8118-8121
9. Rudolph P, Bonichon F, Gloeckner K, Collin F, Chassevent A, Schmidt D, Coindre JM, Parwaresch R, Klöppel G. Comparative analysis of prognostic indicators for sarcomas of the soft parts and the viscerae. Verh Dtsch Ges Path 1998; 82: 246-252
10. Singer S, Rubin BP, Lux ML, Chen C-J, Demetri GD, Fletcher CDM, Fletcher JA. Prognostic value of kit mutation type, mitotic activity and histologic subtype in Gastrointestinal Stromal Tumors. J Clin Oncol 2002; 20: 3898-3905
11. Singh RK, Bucana CD, Gutman M, Fan D, Wilson MR, Fidler IJ. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. Am J Pathol 1994; 145: 365-374
12. Stelzner S, Antoni C, Haroske G, Jacobasch L, Erk JU, Ludwig K. Welche Form der Nachsorge ist bei Patienten mit R0-resezierten gastrointestinalen Stromatumoren (GIST) sinnvoll? Zentralbl Chir 2005; 130: 554-561
13. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y. Effect of c-kit mutation on prognosis of Gastrointestinal Stromal Tumors. Cancer Res 1999; 59: 4297-4300